Nexus Pharmaceuticals to build sterile injectable production facility in Wisconsin

This article was originally published here

Nexus has entered into an agreement with Wisconsin’s village Pleasant Prairie for the development of a sterile injectable manufacturing facility. Expected to be completed in 10 years, the

The post Nexus Pharmaceuticals to build sterile injectable production facility in Wisconsin appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply